Re:Pfizer board member suggests end to mask, vaccine mandates
by walterbell on Wednesday January 26, 2022 @11:28AM
(#30087557)
Progress is slowly being made on transparency. For the Omicron-specific Pfizer vaccine, the clinical trial in humans must be completed before approval and clinical trial data must be submitted at the same time (no 75-year delays).
> recent study from Israel showed that while a fourth dose of an mRNA vaccine boosted antibodies, the level was not high enough to prevent infection by the Omicron variant ... the debate appears to have shifted with the European Medicines Agency (EMA) saying on Friday that international regulators now preferred clinical studies to be carried out before approval of a new vaccine ... it may not be possible to realise a current plan to launch an Omicron-targeting vaccine by the end of March ... Inclusion of clinical trial data in the regulatory filings may have an impact on the delivery of initial batches.
https://www.reuters.com/business/healthcare-pharmaceuticals/...
> recent study from Israel showed that while a fourth dose of an mRNA vaccine boosted antibodies, the level was not high enough to prevent infection by the Omicron variant ... the debate appears to have shifted with the European Medicines Agency (EMA) saying on Friday that international regulators now preferred clinical studies to be carried out before approval of a new vaccine ... it may not be possible to realise a current plan to launch an Omicron-targeting vaccine by the end of March ... Inclusion of clinical trial data in the regulatory filings may have an impact on the delivery of initial batches.